MYXEDEMA HEART
- 17 October 1953
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 153 (7) , 639-642
- https://doi.org/10.1001/jama.1953.02940240031009a
Abstract
Recent spectacular surgical therapy in certain cases of heart failure due to congenital anomalies and rheumatic valvular deformities seems to have overshadowed the fact that medical treatment also can produce dramatic improvement in cardiac decompensation from some types of heart disease. Among these, cardiac impairment resulting from thyroid deficiency can apparently be completely corrected. This is not true of the great majority of cases of heart disease, whether medical, surgical, or combined methods of treatment are used. The fact that myxedema in humans can cause diffuse cardiac enlargement, sluggish contractions, and electrocardiographic abnormalities that disappear only after the myxedema is controlled was recorded by Zondek in 1918. Fahr's investigations in this country in 1925 confirmed Zondek's observations and showed that cardiac volume in cases of severe myxedema may be increased 100%. Lerman, Clark, and Means in 1933 showed reduction in the transverse cardiac diameters in 37 out of 48 casesKeywords
This publication has 7 references indexed in Scilit:
- Myxedema heart, atrial septal defect and hypertension, and congestive heart failureAmerican Heart Journal, 1951
- PERICARDIAL EFFUSIONThe Lancet Healthy Longevity, 1949
- ANTERIOR PITUITARY INSUFFICIENCY (PANHYPOPITUITARISM—SIMMONDS' DISEASE), PITUITARY MYXEDEMA AND CONGESTIVE HEART FAILURE (MYXEDEMA HEART); REPORT OF CASE AND FINDINGS AT NECROPSYAnnals of Internal Medicine, 1948
- MYXEDEMA HEART: A PATHOLOGICAL AND THERAPEUTIC STUDYAnnals of Internal Medicine, 1943
- The duration of electrical systole (Q-T interval) in cases of massive pericardial effusionAmerican Heart Journal, 1941
- MYXEDEMA HEART; REPORT OF A CASEAnnals of Internal Medicine, 1941
- The Heart in Myxedema*†Annals of Internal Medicine, 1933